{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T19:21:55Z","timestamp":1793992915991,"version":"4.8.0"},"reference-count":155,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:00:00Z","timestamp":1772755200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jhep.2026.03.004","type":"journal-article","created":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T11:36:28Z","timestamp":1782992188000},"page":"695-711","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Advances in the imaging of liver cancer"],"prefix":"10.1016","volume":"85","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1341-4072","authenticated-orcid":false,"given":"Ijin","family":"Joo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0561-8777","authenticated-orcid":false,"given":"Jeong Min","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7464-3939","authenticated-orcid":false,"given":"Maxime","family":"Ronot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10504","key":"10.1016\/j.jhep.2026.03.004_bib1","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0140-6736(25)01042-6","article-title":"The Lancet Commission on addressing the global hepatocellular carcinoma burden: comprehensive strategies from prevention to treatment","volume":"406","author":"Chan","year":"2025","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.jhep.2026.03.004_bib2","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1102\/1470-7330.2012.0044","article-title":"Imaging of hepatocellular carcinoma: diagnosis, staging and treatment monitoring","volume":"12","author":"Hennedige","year":"2013","journal-title":"Cancer Imaging"},{"issue":"3","key":"10.1016\/j.jhep.2026.03.004_bib3","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1148\/radiol.2018181494","article-title":"Liver imaging reporting and data system (LI-RADS) version 2018: imaging of hepatocellular carcinoma in at-risk patients","volume":"289","author":"Chernyak","year":"2018","journal-title":"Radiology"},{"issue":"2","key":"10.1016\/j.jhep.2026.03.004_bib4","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jhep.2024.08.028","article-title":"EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma","volume":"82","year":"2025","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.jhep.2026.03.004_bib5","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/hepr.13892","article-title":"Clinical practice guidelines for hepatocellular carcinoma: the Japan society of hepatology 2021 version (5th JSH-HCC guidelines)","volume":"53","author":"Hasegawa","year":"2023","journal-title":"Hepatol Res"},{"issue":"12","key":"10.1016\/j.jhep.2026.03.004_bib6","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.3348\/kjr.2022.0822","article-title":"2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma","volume":"23","author":"Korean Liver Cancer","year":"2022","journal-title":"Korean J Radiol"},{"issue":"4","key":"10.1016\/j.jhep.2026.03.004_bib7","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s12072-017-9799-9","article-title":"Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update","volume":"11","author":"Omata","year":"2017","journal-title":"Hepatol Int"},{"issue":"6","key":"10.1016\/j.jhep.2026.03.004_bib8","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1097\/HEP.0000000000000466","article-title":"AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma","volume":"78","author":"Singal","year":"2023","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.jhep.2026.03.004_bib9","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1148\/radiol.2019190183","article-title":"Contrast-enhanced US with perfluorobutane for hepatocellular carcinoma surveillance: a multicenter diagnostic trial (SCAN)","volume":"292","author":"Park","year":"2019","journal-title":"Radiology"},{"issue":"10","key":"10.1016\/j.jhep.2026.03.004_bib10","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1016\/j.ultrasmedbio.2020.04.030","article-title":"Guidelines and good clinical practice recommendations for contrast-enhanced ultrasound (CEUS) in the liver-update 2020 WFUMB in Cooperation with EFSUMB, AFSUMB, AIUM, and FLAUS","volume":"46","author":"Dietrich","year":"2020","journal-title":"Ultrasound Med Biol"},{"issue":"4","key":"10.1016\/j.jhep.2026.03.004_bib11","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/s00261-017-1392-0","article-title":"Contrast-enhanced ultrasound of the liver: technical and lexicon recommendations from the ACR CEUS LI-RADS working group","volume":"43","author":"Lyshchik","year":"2018","journal-title":"Abdom Radiol (NY)"},{"issue":"3","key":"10.1016\/j.jhep.2026.03.004_bib12","doi-asserted-by":"crossref","first-page":"191","DOI":"10.14366\/usg.20057","article-title":"The AFSUMB consensus statements and recommendations for the clinical practice of contrast-enhanced ultrasound using sonazoid","volume":"39","author":"Lee","year":"2020","journal-title":"Ultrasonography"},{"issue":"11","key":"10.1016\/j.jhep.2026.03.004_bib13","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1177\/02841851211052993","article-title":"Impact of dual-energy 50-keV virtual monoenergetic images on radiologist confidence in detection of key imaging findings of small hepatocellular carcinomas using multiphase liver CT","volume":"63","author":"Voss","year":"2022","journal-title":"Acta Radiol"},{"issue":"5","key":"10.1016\/j.jhep.2026.03.004_bib14","doi-asserted-by":"crossref","first-page":"3468","DOI":"10.1007\/s00330-020-07379-3","article-title":"Virtual monoenergetic images from spectral detector computed tomography facilitate washout assessment in arterially hyper-enhancing liver lesions","volume":"31","author":"Reimer","year":"2021","journal-title":"Eur Radiol"},{"issue":"7","key":"10.1016\/j.jhep.2026.03.004_bib15","article-title":"Dual-energy CT for the detection of portal vein thrombosis: improved diagnostic performance using virtual monoenergetic reconstructions","volume":"12","author":"Martin","year":"2022","journal-title":"Diagnostics (Basel)"},{"issue":"2","key":"10.1016\/j.jhep.2026.03.004_bib16","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1148\/radiol.2018172656","article-title":"Photon-counting CT: technical principles and clinical prospects","volume":"289","author":"Willemink","year":"2018","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.jhep.2026.03.004_bib17","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s40644-025-00922-9","article-title":"LI-RADS: concordance between energy-integrating computed tomography, photon-counting detector computed tomography and magnetic resonance imaging","volume":"25","author":"Muller","year":"2025","journal-title":"Cancer Imaging"},{"issue":"1","key":"10.1016\/j.jhep.2026.03.004_bib18","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1148\/radiol.14140690","article-title":"Hepatocellular carcinoma: diagnostic performance of multidetector CT and MR imaging-a systematic review and meta-analysis","volume":"275","author":"Lee","year":"2015","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.jhep.2026.03.004_bib19","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1148\/radiol.14132362","article-title":"CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part II. Extracellular agents, hepatobiliary agents, and ancillary imaging features","volume":"273","author":"Choi","year":"2014","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.jhep.2026.03.004_bib20","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1148\/radiol.2017162080","article-title":"Diagnostic performance of gadoxetic acid-enhanced liver MR imaging versus multidetector CT in the detection of dysplastic nodules and early hepatocellular carcinoma","volume":"285","author":"Kim","year":"2017","journal-title":"Radiology"},{"issue":"4","key":"10.1016\/j.jhep.2026.03.004_bib21","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jceh.2016.08.012","article-title":"Role of diffusion weighted imaging (DWI) for hepatocellular carcinoma (HCC) detection and its grading on 3T MRI: a prospective study","volume":"6","author":"Shankar","year":"2016","journal-title":"J Clin Exp Hepatol"},{"issue":"10","key":"10.1016\/j.jhep.2026.03.004_bib22","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1007\/s00330-009-1431-5","article-title":"Diffusion-weighted MRI provides additional value to conventional dynamic contrast-enhanced MRI for detection of hepatocellular carcinoma","volume":"19","author":"Vandecaveye","year":"2009","journal-title":"Eur Radiol"},{"issue":"11","key":"10.1016\/j.jhep.2026.03.004_bib23","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.7150\/jca.14582","article-title":"Hepatocellular carcinoma and diffusion-weighted MRI: detection and evaluation of treatment response","volume":"7","author":"Gluskin","year":"2016","journal-title":"J Cancer"},{"issue":"1","key":"10.1016\/j.jhep.2026.03.004_bib24","doi-asserted-by":"crossref","first-page":"31","DOI":"10.17998\/jlc.2025.02.16","article-title":"Recent advances and issues in imaging modalities for hepatocellular carcinoma surveillance","volume":"25","author":"Lee","year":"2025","journal-title":"J Liver Cancer"},{"issue":"3","key":"10.1016\/j.jhep.2026.03.004_bib25","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jhep.2024.03.048","article-title":"Comparison of non-contrast abbreviated MRI and ultrasound as surveillance modalities for HCC","volume":"81","author":"Kim","year":"2024","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.jhep.2026.03.004_bib26","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1053\/j.gastro.2024.12.035","article-title":"Noncontrast magnetic resonance imaging vs ultrasonography for hepatocellular carcinoma surveillance: a randomized, single-center trial","volume":"168","author":"Rhee","year":"2025","journal-title":"Gastroenterology"},{"issue":"32","key":"10.1016\/j.jhep.2026.03.004_bib27","doi-asserted-by":"crossref","first-page":"4682","DOI":"10.3748\/wjg.v25.i32.4682","article-title":"Positron-emission tomography for hepatocellular carcinoma: current status and future prospects","volume":"25","author":"Lu","year":"2019","journal-title":"World J Gastroenterol"},{"issue":"7","key":"10.1016\/j.jhep.2026.03.004_bib28","article-title":"Dual-tracer PET\/CT in the management of hepatocellular carcinoma","volume":"6","author":"Chiu","year":"2024","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhep.2026.03.004_bib29","article-title":"18F-FDG\/18F-choline dual-tracer PET behavior and tumor differentiation in HepatoCellular carcinoma. A systematic review","volume":"9","author":"Ghidaglia","year":"2022","journal-title":"Front Med (Lausanne)"},{"issue":"4","key":"10.1016\/j.jhep.2026.03.004_bib30","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/S2468-1253(25)00011-1","article-title":"[18F]fluorodeoxyglucose and [18F]fluorocholine PET-CT for staging optimisation and treatment modification in hepatocellular carcinoma (PET-HCC01): a prospective multicentre study","volume":"10","author":"Nault","year":"2025","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2026.03.004_bib31","doi-asserted-by":"crossref","first-page":"379","DOI":"10.21037\/hbsn-23-675","article-title":"(18)F-fluorodeoxyglucose positron emission tomography\/computed tomography in intrahepatic cholangiocarcinoma: could it be a new paradigm?","volume":"13","author":"Tsurusaki","year":"2024","journal-title":"Hepatobiliary Surg Nutr"},{"key":"10.1016\/j.jhep.2026.03.004_bib32","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1080\/17434440.2019.1608817","article-title":"Recent advances in PET probes for hepatocellular carcinoma characterization","volume":"16","author":"Filippi","year":"2019","journal-title":"Expert Rev Med Devices"},{"key":"10.1016\/j.jhep.2026.03.004_bib33","doi-asserted-by":"crossref","first-page":"4200","DOI":"10.1007\/s00259-025-07264-5","article-title":"Comparative diagnostic performance of [68 Ga]Ga-FAPI PET\/CT and [18 F]FDGPET\/CT in biliary tract cancers: a systematic review and meta-analysis","volume":"52","author":"Msherghi","year":"2025","journal-title":"Eur J Nucl Med Mol Imag"},{"key":"10.1016\/j.jhep.2026.03.004_bib34","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/s00261-016-0947-9","article-title":"Current clinical status of (18)F-FLT PET or PET\/CT in digestive and abdominal organ oncology","volume":"42","author":"Nakajo","year":"2017","journal-title":"Abdom Radiol (NY)"},{"key":"10.1016\/j.jhep.2026.03.004_bib35","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s11010-022-04483-4","article-title":"Novel antigens for targeted radioimmunotherapy in hepatocellular carcinoma","volume":"478","author":"Pourhamzeh","year":"2023","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.jhep.2026.03.004_bib36","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.acra.2020.01.026","article-title":"The role of 18F-FDG PET\/MRI in the assessment of primary intrahepatic neoplasms","volume":"28","author":"Celebi","year":"2021","journal-title":"Acad Radiol"},{"issue":"1","key":"10.1016\/j.jhep.2026.03.004_bib37","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00261-017-1250-0","article-title":"Ceus LI-RADS: algorithm, implementation, and key differences from CT\/MRI","volume":"43","author":"Wilson","year":"2018","journal-title":"Abdom Radiol (NY)"},{"issue":"3","key":"10.1016\/j.jhep.2026.03.004_bib38","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.241856","article-title":"LI-RADS for diagnosing hepatocellular carcinoma in patients with noncirrhotic chronic hepatitis C","volume":"314","author":"An","year":"2025","journal-title":"Radiology"},{"issue":"6","key":"10.1016\/j.jhep.2026.03.004_bib39","article-title":"Non-invasive imaging criteria for the diagnosis of hepatocellular carcinoma in non-cirrhotic patients with chronic hepatitis B","volume":"3","author":"Moctezuma-Velazquez","year":"2021","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhep.2026.03.004_bib40","article-title":"HCV eradication induced by direct-acting antiviral agents reduces the risk of hepatocellular carcinoma","author":"Ioannou","year":"2017","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.jhep.2026.03.004_bib41","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.jhep.2015.01.002","article-title":"Risk of hepatocellular carcinoma in chronic hepatitis B: assessment and modification with current antiviral therapy","volume":"62","author":"Papatheodoridis","year":"2015","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.jhep.2026.03.004_bib42","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.jhep.2019.01.009","article-title":"Low specificity of washout to diagnose hepatocellular carcinoma in nodules showing arterial hyperenhancement in patients with Budd-Chiari syndrome","volume":"70","author":"Van Wettere","year":"2019","journal-title":"J Hepatol"},{"issue":"11","key":"10.1016\/j.jhep.2026.03.004_bib43","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1007\/s00261-017-1181-9","article-title":"Benign nodules in post-Fontan livers can show imaging features considered diagnostic for hepatocellular carcinoma","volume":"42","author":"Wells","year":"2017","journal-title":"Abdom Radiol (NY)"},{"issue":"6","key":"10.1016\/j.jhep.2026.03.004_bib44","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1053\/j.gastro.2018.08.024","article-title":"Risk of hepatocellular cancer in patients with non-alcoholic fatty liver disease","volume":"155","author":"Kanwal","year":"2018","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.jhep.2026.03.004_bib45","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1002\/jmri.27783","article-title":"Hepatic steatosis has No effect in diagnosis accuracy of LI-RADS v2018 categorization of hepatocellular carcinoma in MR imaging","volume":"59","author":"Yao","year":"2024","journal-title":"J Magn Reson Imag"},{"issue":"12","key":"10.1016\/j.jhep.2026.03.004_bib46","doi-asserted-by":"crossref","first-page":"7622","DOI":"10.1007\/s00330-024-10846-w","article-title":"Diagnostic performance of CT\/MRI LI-RADS v2018 in non-cirrhotic steatotic liver disease","volume":"34","author":"Cao","year":"2024","journal-title":"Eur Radiol"},{"issue":"10","key":"10.1016\/j.jhep.2026.03.004_bib47","doi-asserted-by":"crossref","first-page":"887","DOI":"10.3348\/kjr.2024.0307","article-title":"Advances in understanding hepatocellular carcinoma vasculature: implications for diagnosis, prognostication, and treatment","volume":"25","author":"Rhee","year":"2024","journal-title":"Korean J Radiol"},{"issue":"2","key":"10.1016\/j.jhep.2026.03.004_bib48","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1148\/radiol.2021211244","article-title":"CT\/MRI and CEUS LI-RADS major features association with hepatocellular carcinoma: individual patient data meta-analysis","volume":"302","author":"van der Pol","year":"2022","journal-title":"Radiology"},{"issue":"8","key":"10.1016\/j.jhep.2026.03.004_bib49","doi-asserted-by":"crossref","first-page":"5134","DOI":"10.1007\/s00330-022-08665-y","article-title":"Do transition and hepatobiliary phase hypointensity improve LI-RADS categorization as an alternative washout: a systematic review and meta-analysis","volume":"32","author":"Pan","year":"2022","journal-title":"Eur Radiol"},{"issue":"3","key":"10.1016\/j.jhep.2026.03.004_bib50","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.243450","article-title":"Diagnostic performance of CT\/MRI LI-RADS version 2018 major feature combinations: individual participant data meta-analysis","volume":"315","author":"Adamo","year":"2025","journal-title":"Radiology"},{"issue":"3","key":"10.1016\/j.jhep.2026.03.004_bib51","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.jhep.2022.11.006","article-title":"Value of threshold growth as a major diagnostic feature of hepatocellular carcinoma in LI-RADS","volume":"78","author":"Choi","year":"2023","journal-title":"J Hepatol"},{"issue":"10","key":"10.1016\/j.jhep.2026.03.004_bib52","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.3348\/kjr.2020.1341","article-title":"Should threshold growth Be considered a major feature in the diagnosis of hepatocellular carcinoma using LI-RADS?","volume":"22","author":"Park","year":"2021","journal-title":"Korean J Radiol"},{"issue":"2","key":"10.1016\/j.jhep.2026.03.004_bib53","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1007\/s00261-023-04114-6","article-title":"A multi-parameter intrahepatic cholangiocarcinoma scoring system based on modified contrast-enhanced ultrasound LI-RADS M criteria for differentiating intrahepatic cholangiocarcinoma from hepatocellular carcinoma","volume":"49","author":"Wang","year":"2024","journal-title":"Abdom Radiol (NY)"},{"issue":"7","key":"10.1016\/j.jhep.2026.03.004_bib54","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.ultrasmedbio.2024.03.016","article-title":"Dynamic contrast-enhanced ultrasonography combined with LR-M classification criteria for differentiating malignant liver nodules at high risk for hepatocellular carcinoma","volume":"50","author":"Qiu","year":"2024","journal-title":"Ultrasound Med Biol"},{"issue":"2","key":"10.1016\/j.jhep.2026.03.004_bib55","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.230150","article-title":"Contrast-enhanced US with sulfur hexafluoride and perfluorobutane: LI-RADS for diagnosing hepatocellular carcinoma","volume":"308","author":"Li","year":"2023","journal-title":"Radiology"},{"issue":"2","key":"10.1016\/j.jhep.2026.03.004_bib56","doi-asserted-by":"crossref","DOI":"10.2214\/AJR.23.30156","article-title":"Contrast-enhanced ultrasound with perfluorobutane for hepatocellular carcinoma diagnosis: comparison of imaging phases and diagnostic criteria","volume":"222","author":"Kang","year":"2024","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"10.1016\/j.jhep.2026.03.004_bib57","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s00261-017-1196-2","article-title":"LI-RADS M (LR-M): definite or probable malignancy, not specific for hepatocellular carcinoma","volume":"43","author":"Fowler","year":"2018","journal-title":"Abdom Radiol (NY)"},{"issue":"2","key":"10.1016\/j.jhep.2026.03.004_bib58","doi-asserted-by":"crossref","first-page":"217","DOI":"10.17998\/jlc.2025.07.29","article-title":"Preventing false positive imaging diagnosis of HCC: differentiating HCC from mimickers and practical strategies","volume":"25","author":"Joo","year":"2025","journal-title":"J Liver Cancer"},{"issue":"1","key":"10.1016\/j.jhep.2026.03.004_bib59","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.220646","article-title":"Percentages of hepatocellular carcinoma in LI-RADS categories with CT and MRI: a systematic review and meta-analysis","volume":"307","author":"Lee","year":"2023","journal-title":"Radiology"},{"issue":"2","key":"10.1016\/j.jhep.2026.03.004_bib60","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/RLI.0b013e3181c5faf7","article-title":"Gadoxetic acid-enhanced magnetic resonance imaging for differentiating small hepatocellular carcinomas (< or =2 cm in diameter) from arterial enhancing pseudolesions: special emphasis on hepatobiliary phase imaging","volume":"45","author":"Sun","year":"2010","journal-title":"Invest Radiol"},{"issue":"2","key":"10.1016\/j.jhep.2026.03.004_bib61","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1148\/radiol.2020192275","article-title":"Radiologic-pathologic correlation of hepatobiliary phase hypointense nodules without arterial phase hyperenhancement at gadoxetic acid-enhanced MRI: a multicenter study","volume":"296","author":"Joo","year":"2020","journal-title":"Radiology"},{"issue":"2","key":"10.1016\/j.jhep.2026.03.004_bib62","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.acra.2020.08.031","article-title":"Risk factors for hypervascularization in hepatobiliary phase hypointense nodules without arterial phase hyperenhancement: a systematic review and meta-analysis","volume":"29","author":"Kim","year":"2022","journal-title":"Acad Radiol"},{"issue":"7","key":"10.1016\/j.jhep.2026.03.004_bib63","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1148\/rg.2018180052","article-title":"LI-RADS version 2018 ancillary features at MRI","volume":"38","author":"Cerny","year":"2018","journal-title":"Radiographics"},{"issue":"2","key":"10.1016\/j.jhep.2026.03.004_bib64","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.231501","article-title":"LI-RADS CT and MRI ancillary feature association with hepatocellular carcinoma and malignancy: an individual participant data meta-analysis","volume":"310","author":"Dawit","year":"2024","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.jhep.2026.03.004_bib65","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s00330-021-08116-0","article-title":"LI-RADS v2018: how to appropriately use ancillary features in category adjustment from intermediate probability of malignancy (LR-3) to probably HCC (LR-4) on gadoxetic acid-enhanced MRI","volume":"32","author":"Jeon","year":"2022","journal-title":"Eur Radiol"},{"issue":"5","key":"10.1016\/j.jhep.2026.03.004_bib66","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1007\/s00330-019-06645-3","article-title":"Ancillary features in the Liver Imaging Reporting and Data System: how to improve diagnosis of hepatocellular carcinoma <\/= 3 cm on magnetic resonance imaging","volume":"30","author":"Kang","year":"2020","journal-title":"Eur Radiol"},{"issue":"1","key":"10.1016\/j.jhep.2026.03.004_bib67","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.242278","article-title":"Impact of LI-RADS CT and MRI ancillary features on diagnostic performance: an individual participant data meta-analysis","volume":"316","author":"Abedrabbo","year":"2025","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.jhep.2026.03.004_bib68","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1148\/radiol.2018171187","article-title":"Imaging diagnosis of intrahepatic and perihilar cholangiocarcinoma: recent advances and challenges","volume":"288","author":"Joo","year":"2018","journal-title":"Radiology"},{"issue":"2","key":"10.1016\/j.jhep.2026.03.004_bib69","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/his.13975","article-title":"The 2019 WHO classification of tumours of the digestive system","volume":"76","author":"Nagtegaal","year":"2020","journal-title":"Histopathology"},{"issue":"1","key":"10.1016\/j.jhep.2026.03.004_bib70","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jhep.2023.03.010","article-title":"EASL-ILCA Clinical Practice Guidelines on the management of intrahepatic cholangiocarcinoma","volume":"79","year":"2023","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.jhep.2026.03.004_bib71","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1159\/000521747","article-title":"Subtype classification of intrahepatic cholangiocarcinoma using liver MR imaging features and its prognostic value","volume":"11","author":"Park","year":"2022","journal-title":"Liver Cancer"},{"issue":"6","key":"10.1016\/j.jhep.2026.03.004_bib72","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.1007\/s00330-018-5898-9","article-title":"Proposal of imaging classification of intrahepatic mass-forming cholangiocarcinoma into ductal and parenchymal types: clinicopathologic significance","volume":"29","author":"Rhee","year":"2019","journal-title":"Eur Radiol"},{"issue":"3","key":"10.1016\/j.jhep.2026.03.004_bib73","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/RCT.0000000000000695","article-title":"Intrahepatic mass-forming cholangiocarcinoma: relationship between computed tomography characteristics and histological subtypes","volume":"42","author":"Nam","year":"2018","journal-title":"J Comput Assist Tomogr"},{"issue":"1","key":"10.1016\/j.jhep.2026.03.004_bib74","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1148\/radiol.2016151205","article-title":"Small intrahepatic cholangiocarcinoma and hepatocellular carcinoma in cirrhotic livers may share similar enhancement patterns at multiphase dynamic MR imaging","volume":"281","author":"Huang","year":"2016","journal-title":"Radiology"},{"issue":"6","key":"10.1016\/j.jhep.2026.03.004_bib75","first-page":"629","article-title":"LI-RADS category can Be a post-surgical prognostic factor for intrahepatic cholangiocarcinoma in patients with liver cirrhosis or chronic hepatitis B","volume":"13","author":"Park","year":"2024","journal-title":"Liver Cancer"},{"issue":"5","key":"10.1016\/j.jhep.2026.03.004_bib76","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1002\/jmri.25287","article-title":"Diagnostic accuracy of liver imaging reporting and data system (LI-RADS) v2014 for intrahepatic mass-forming cholangiocarcinomas in patients with chronic liver disease on gadoxetic acid-enhanced MRI","volume":"44","author":"Joo","year":"2016","journal-title":"J Magn Reson Imag"},{"issue":"3","key":"10.1016\/j.jhep.2026.03.004_bib77","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1002\/jmri.28354","article-title":"LI-RADS category on MRI is associated with recurrence of intrahepatic cholangiocarcinoma after surgery: a multicenter study","volume":"57","author":"Hwang","year":"2023","journal-title":"J Magn Reson Imag"},{"issue":"4","key":"10.1016\/j.jhep.2026.03.004_bib78","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1053\/j.gastro.2016.11.048","article-title":"Liver cancer cell of origin, molecular class, and effects on patient prognosis","volume":"152","author":"Sia","year":"2017","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.jhep.2026.03.004_bib79","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1002\/hep.25890","article-title":"Transcriptomic profiling reveals hepatic stem-like gene signatures and interplay of miR-200c and epithelial-mesenchymal transition in intrahepatic cholangiocarcinoma","volume":"56","author":"Oishi","year":"2012","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.jhep.2026.03.004_bib80","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/hep.32397","article-title":"Molecular and radiopathologic spectrum between HCC and intrahepatic cholangiocarcinoma","volume":"77","author":"Jeon","year":"2023","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.jhep.2026.03.004_bib81","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/j.jhep.2021.01.035","article-title":"Combined hepatocellular-cholangiocarcinoma: an update","volume":"74","author":"Beaufrere","year":"2021","journal-title":"J Hepatol"},{"issue":"12","key":"10.1016\/j.jhep.2026.03.004_bib82","doi-asserted-by":"crossref","first-page":"9479","DOI":"10.1007\/s00330-021-07984-w","article-title":"Radio-pathologic correlation of biphenotypic primary liver cancer (combined hepatocellular cholangiocarcinoma): changes in the 2019 WHO classification and impact on LI-RADS classification at liver MRI","volume":"31","author":"Choi","year":"2021","journal-title":"Eur Radiol"},{"issue":"1","key":"10.1016\/j.jhep.2026.03.004_bib83","doi-asserted-by":"crossref","first-page":"12","DOI":"10.17998\/jlc.21.1.12","article-title":"Update on pathologic and radiologic diagnosis of combined hepatocellular-cholangiocarcinoma","volume":"21","author":"Rhee","year":"2021","journal-title":"J Liver Cancer"},{"issue":"1","key":"10.1016\/j.jhep.2026.03.004_bib84","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/jmri.25568","article-title":"Combined hepatocellular-cholangiocarcinoma: gadoxetic acid-enhanced MRI findings correlated with pathologic features and prognosis","volume":"46","author":"Park","year":"2017","journal-title":"J Magn Reson Imag"},{"key":"10.1016\/j.jhep.2026.03.004_bib85","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.jhep.2017.05.014","article-title":"Histological subtypes of hepatocellular carcinoma are related to gene mutations and molecular tumour classification","volume":"67","author":"Calderaro","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2026.03.004_bib86","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.jhep.2019.06.001","article-title":"Molecular and histological correlations in liver cancer","volume":"71","author":"Calderaro","year":"2019","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.jhep.2026.03.004_bib87","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/hep.21467","article-title":"Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets","volume":"45","author":"Boyault","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2026.03.004_bib88","series-title":"Digestive system tumours","first-page":"229","year":"2019"},{"issue":"2","key":"10.1016\/j.jhep.2026.03.004_bib89","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.220531","article-title":"Dynamic CT and gadoxetic acid-enhanced MRI characteristics of P53-mutated hepatocellular carcinoma","volume":"306","author":"Kitao","year":"2023","journal-title":"Radiology"},{"issue":"5","key":"10.1016\/j.jhep.2026.03.004_bib90","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.jhep.2014.06.008","article-title":"OATP1B3 expression is strongly associated with Wnt\/\u03b2-catenin signalling and represents the transporter of gadoxetic acid in hepatocellular carcinoma","volume":"61","author":"Ueno","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2026.03.004_bib91","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/hep.29762","article-title":"Macrotrabecular-massive hepatocellular carcinoma: a distinctive histological subtype with clinical relevance","volume":"68","author":"Ziol","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2026.03.004_bib92","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1097\/PAS.0000000000001289","article-title":"Macrotrabecular hepatocellular carcinoma: an aggressive subtype of hepatocellular carcinoma","volume":"43","author":"Jeon","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jhep.2026.03.004_bib93","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1148\/radiol.2020192230","article-title":"Multiphase liver MRI for identifying the macrotrabecular-massive subtype of hepatocellular carcinoma","volume":"295","author":"Mul\u00e9","year":"2020","journal-title":"Radiology"},{"issue":"6","key":"10.1016\/j.jhep.2026.03.004_bib94","article-title":"Imaging features of histological subtypes of hepatocellular carcinoma: implication for LI-RADS","volume":"3","author":"Cannella","year":"2021","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhep.2026.03.004_bib95","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1148\/radiol.2021203614","article-title":"Preoperative CT for characterization of aggressive macrotrabecular-massive subtype and vessels that encapsulate tumor clusters pattern in hepatocellular carcinoma","volume":"300","author":"Feng","year":"2021","journal-title":"Radiology"},{"issue":"2","key":"10.1016\/j.jhep.2026.03.004_bib96","doi-asserted-by":"crossref","first-page":"212","DOI":"10.2214\/AJR.21.26982","article-title":"Variant hepatocellular carcinoma subtypes according to the 2019 WHO classification: an imaging-focused review","volume":"219","author":"Loy","year":"2022","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.jhep.2026.03.004_bib97","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1097\/PAS.0b013e3181f31caa","article-title":"Steatohepatitic hepatocellular carcinoma (SH-HCC): a distinctive histological variant of HCC in hepatitis C virus-related cirrhosis with associated NAFLD\/NASH","volume":"34","author":"Salomao","year":"2010","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1016\/j.jhep.2026.03.004_bib98","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s11547-024-01807-w","article-title":"Imaging and prognostic characterization of fat-containing hepatocellular carcinoma subtypes","volume":"129","author":"Faure","year":"2024","journal-title":"Radiol Med"},{"issue":"2","key":"10.1016\/j.jhep.2026.03.004_bib99","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.233471","article-title":"Prognostic implications of MRI-assessed intratumoral fat in hepatocellular carcinoma: an asian and European cohort study","volume":"313","author":"Jiang","year":"2024","journal-title":"Radiology"},{"issue":"6","key":"10.1016\/j.jhep.2026.03.004_bib100","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1002\/hep.28710","article-title":"Programmed death ligand 1 expression in hepatocellular carcinoma: relationship with clinical and pathological features","volume":"64","author":"Calderaro","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2026.03.004_bib101","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jhep.2019.08.017","article-title":"Advances in molecular classification and precision oncology in hepatocellular carcinoma","volume":"72","author":"Rebouissou","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2026.03.004_bib102","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1053\/j.gastro.2017.06.007","article-title":"Identification of an immune-specific class of hepatocellular carcinoma, based on molecular features","volume":"153","author":"Sia","year":"2017","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.jhep.2026.03.004_bib103","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/hep.32573","article-title":"Multiomics identifies the link between intratumor steatosis and the exhausted tumor immune microenvironment in hepatocellular carcinoma","volume":"77","author":"Murai","year":"2023","journal-title":"Hepatology"},{"issue":"17","key":"10.1016\/j.jhep.2026.03.004_bib104","doi-asserted-by":"crossref","first-page":"4234","DOI":"10.3390\/cancers15174234","article-title":"Association of hepatobiliary phase of gadoxetic-acid-enhanced MRI imaging with immune microenvironment and response to atezolizumab plus bevacizumab treatment","volume":"15","author":"Tamura","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.jhep.2026.03.004_bib105","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s00262-021-02957-w","article-title":"Imaging features of gadoxetic acid-enhanced MR imaging for evaluation of tumor-infiltrating CD8 cells and PD-L1 expression in hepatocellular carcinoma","volume":"71","author":"Sun","year":"2022","journal-title":"Cancer Immunol Immunother"},{"issue":"1","key":"10.1016\/j.jhep.2026.03.004_bib106","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-15491-6","article-title":"A non-smooth tumor margin on preoperative imaging assesses microvascular invasion of hepatocellular carcinoma: a systematic review and meta-analysis","volume":"7","author":"Hu","year":"2017","journal-title":"Sci Rep"},{"issue":"9","key":"10.1016\/j.jhep.2026.03.004_bib107","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1007\/s00261-019-02126-9","article-title":"Incomplete tumor capsule on preoperative imaging reveals microvascular invasion in hepatocellular carcinoma: a systematic review and meta-analysis","volume":"44","author":"Zhu","year":"2019","journal-title":"Abdom Radiol (NY)"},{"issue":"3","key":"10.1016\/j.jhep.2026.03.004_bib108","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.jhep.2017.04.024","article-title":"Preoperative gadoxetic acid-enhanced MRI for predicting microvascular invasion in patients with single hepatocellular carcinoma","volume":"67","author":"Lee","year":"2017","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.jhep.2026.03.004_bib109","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1148\/radiol.2015150998","article-title":"Can current preoperative imaging Be used to detect microvascular invasion of hepatocellular carcinoma?","volume":"279","author":"Renzulli","year":"2016","journal-title":"Radiology"},{"issue":"3","key":"10.1016\/j.jhep.2026.03.004_bib110","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/hep.27877","article-title":"A computed tomography radiogenomic biomarker predicts microvascular invasion and clinical outcomes in hepatocellular carcinoma","volume":"62","author":"Banerjee","year":"2015","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.jhep.2026.03.004_bib111","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/hep.30814","article-title":"Vessels encapsulating tumor clusters (VETC) is a powerful predictor of aggressive hepatocellular carcinoma","volume":"71","author":"Renne","year":"2020","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.jhep.2026.03.004_bib112","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1148\/radiol.2021203614","article-title":"Preoperative CT for characterization of aggressive macrotrabecular-massive subtype and vessels that encapsulate tumor clusters pattern in hepatocellular carcinoma","volume":"300","author":"Feng","year":"2021","journal-title":"Radiology"},{"issue":"3","key":"10.1016\/j.jhep.2026.03.004_bib113","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.221429","article-title":"Imaging to predict prognosis in hepatocellular carcinoma: current and future perspectives","volume":"307","author":"Ronot","year":"2023","journal-title":"Radiology"},{"key":"10.1016\/j.jhep.2026.03.004_bib114","doi-asserted-by":"crossref","DOI":"10.1159\/000546966","article-title":"The evolving role of imaging in hepatocellular carcinoma: from pathomolecular profiling to prognostic decision-making","author":"Jiang","year":"2025","journal-title":"Liver Cancer"},{"issue":"9","key":"10.1016\/j.jhep.2026.03.004_bib115","article-title":"Predicting post-resection recurrence by integrating imaging-based surrogates of distinct vascular patterns of hepatocellular carcinoma","volume":"5","author":"Meng","year":"2023","journal-title":"JHEP Rep"},{"issue":"1","key":"10.1016\/j.jhep.2026.03.004_bib116","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00330-023-09998-y","article-title":"LI-RADS category is associated with treatment outcomes of small single HCC: surgical resection vs. radiofrequency ablation","volume":"34","author":"Min","year":"2024","journal-title":"Eur Radiol"},{"issue":"5","key":"10.1016\/j.jhep.2026.03.004_bib117","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1007\/s00330-023-10279-x","article-title":"Prognostic MRI features to predict postresection survivals for very early to intermediate stage hepatocellular carcinoma","volume":"34","author":"Jiang","year":"2024","journal-title":"Eur Radiol"},{"issue":"2","key":"10.1016\/j.jhep.2026.03.004_bib118","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.231160","article-title":"Association of LI-RADS and histopathologic features with survival in patients with solitary resected hepatocellular carcinoma","volume":"310","author":"Cannella","year":"2024","journal-title":"Radiology"},{"issue":"2","key":"10.1016\/j.jhep.2026.03.004_bib119","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1159\/000531786","article-title":"Preoperative prediction of microvascular invasion with gadoxetic acid-enhanced magnetic resonance imaging in patients with single hepatocellular carcinoma: the implication of surgical decision on the extent of liver resection","volume":"13","author":"Kim","year":"2024","journal-title":"Liver Cancer"},{"issue":"4","key":"10.1016\/j.jhep.2026.03.004_bib120","doi-asserted-by":"crossref","DOI":"10.12771\/emj.2024.e66","article-title":"Imaging findings of intrahepatic cholangiocarcinoma for prognosis prediction and treatment decision-making: a narrative review","volume":"47","author":"Kang","year":"2024","journal-title":"Ewha Med J"},{"key":"10.1016\/j.jhep.2026.03.004_bib121","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.2147\/JHC.S461420","article-title":"Radiomics-based prediction of microvascular invasion grade in nodular hepatocellular carcinoma using contrast-enhanced magnetic resonance imaging","volume":"11","author":"Zhang","year":"2024","journal-title":"J Hepatocell Carcinoma"},{"key":"10.1016\/j.jhep.2026.03.004_bib122","article-title":"CT-based radiomics for predicting pathological grade in hepatocellular carcinoma","volume":"14","author":"Huang","year":"2024","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.jhep.2026.03.004_bib123","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.acra.2023.08.001","article-title":"Application of radiomics in the efficacy evaluation of transarterial chemoembolization for hepatocellular carcinoma: a systematic review and meta-analysis","volume":"31","author":"Wang","year":"2024","journal-title":"Acad Radiol"},{"issue":"1","key":"10.1016\/j.jhep.2026.03.004_bib124","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1186\/s12885-025-13978-4","article-title":"Predicting treatment response and prognosis of immune checkpoint inhibitors-based combination therapy in advanced hepatocellular carcinoma using a longitudinal CT-based radiomics model: a multicenter study","volume":"25","author":"Xu","year":"2025","journal-title":"BMC Cancer"},{"issue":"4","key":"10.1016\/j.jhep.2026.03.004_bib125","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1007\/s12072-023-10487-z","article-title":"Artificial intelligence CT radiomics to predict early recurrence of intrahepatic cholangiocarcinoma: a multicenter study","volume":"17","author":"Song","year":"2023","journal-title":"Hepatol Int"},{"issue":"1","key":"10.1016\/j.jhep.2026.03.004_bib126","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13244-023-01365-1","article-title":"Systematic review with radiomics quality score of cholangiocarcinoma: an EuSoMII radiomics auditing group initiative","volume":"14","author":"Cannella","year":"2023","journal-title":"Insights Imaging"},{"issue":"12","key":"10.1016\/j.jhep.2026.03.004_bib127","article-title":"Advancements in artificial intelligence-enhanced imaging diagnostics for the management of liver disease-applications and challenges in personalized care","volume":"11","author":"Nishida","year":"2024","journal-title":"Bioengineering (Basel)"},{"issue":"2","key":"10.1016\/j.jhep.2026.03.004_bib128","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1007\/s00261-020-02564-w","article-title":"Deep learning for differentiation of benign and malignant solid liver lesions on ultrasonography","volume":"46","author":"Xi","year":"2021","journal-title":"Abdom Radiol (NY)"},{"issue":"10","key":"10.1016\/j.jhep.2026.03.004_bib129","article-title":"Improving risk stratification and detection of early HCC using ultrasound-based deep learning models","volume":"7","author":"Dana","year":"2025","journal-title":"JHEP Rep"},{"issue":"10","key":"10.1016\/j.jhep.2026.03.004_bib130","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1111\/jgh.16663","article-title":"Artificial intelligence in hepatocellular carcinoma diagnosis: a comprehensive review of current literature","volume":"39","author":"Chatzipanagiotou","year":"2024","journal-title":"J Gastroenterol Hepatol"},{"issue":"12","key":"10.1016\/j.jhep.2026.03.004_bib131","doi-asserted-by":"crossref","first-page":"8879","DOI":"10.1007\/s00330-023-09857-w","article-title":"Deep learning-assisted LI-RADS grading and distinguishing hepatocellular carcinoma (HCC) from non-HCC based on multiphase CT: a two-center study","volume":"33","author":"Xu","year":"2023","journal-title":"Eur Radiol"},{"issue":"6","key":"10.1016\/j.jhep.2026.03.004_bib132","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.jvir.2018.01.769","article-title":"Predicting treatment response to intra-arterial therapies for hepatocellular carcinoma with the use of supervised machine learning-an artificial intelligence concept","volume":"29","author":"Abajian","year":"2018","journal-title":"J Vasc Interv Radiol"},{"issue":"4","key":"10.1016\/j.jhep.2026.03.004_bib133","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.jhep.2025.04.017","article-title":"Machine learning based radiomic models outperform clinical biomarkers in predicting outcomes after immunotherapy for hepatocellular carcinoma","volume":"83","author":"Vithayathil","year":"2025","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.jhep.2026.03.004_bib134","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1016\/j.jhep.2025.07.003","article-title":"The barriers to uptake of artificial intelligence in hepatology and how to overcome them","volume":"83","author":"Clusmann","year":"2025","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2026.03.004_bib135","article-title":"Evaluation of liver tumour response by imaging","volume":"2","author":"Gregory","year":"2020","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhep.2026.03.004_bib136","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1055\/s-0030-1247132","article-title":"Modified RECIST (mRECIST) assessment for hepatocellular carcinoma","volume":"30","author":"Lencioni","year":"2010","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhep.2026.03.004_bib137","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.232408","article-title":"CT\/MRI LI-RADS 2024 update: treatment response assessment","volume":"313","author":"Aslam","year":"2024","journal-title":"Radiology"},{"key":"10.1016\/j.jhep.2026.03.004_bib138","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.232369","article-title":"Liver imaging reporting and data system contrast-enhanced US nonradiation treatment response assessment version 2024","volume":"311","author":"Lyshchik","year":"2024","journal-title":"Radiology"},{"issue":"11","key":"10.1016\/j.jhep.2026.03.004_bib139","doi-asserted-by":"crossref","first-page":"7349","DOI":"10.1007\/s00330-025-11659-1","article-title":"Temporal evolution of the LI-RADS radiation treatment response assessment on multiphase CT\/MRI in patients undergoing selective internal radiation therapy for hepatocellular carcinoma","volume":"35","author":"Wei","year":"2025","journal-title":"Eur Radiol"},{"key":"10.1016\/j.jhep.2026.03.004_bib140","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.3348\/kjr.2022.0225","article-title":"Evolution of radiological treatment response assessments for cancer immunotherapy: from iRECIST to radiomics and artificial intelligence","volume":"23","author":"Kim","year":"2022","journal-title":"Korean J Radiol"},{"key":"10.1016\/j.jhep.2026.03.004_bib141","doi-asserted-by":"crossref","first-page":"e143","DOI":"10.1016\/S1470-2045(17)30074-8","article-title":"iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics","volume":"18","author":"Seymour","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jhep.2026.03.004_bib142","article-title":"Outcome of initial progression during nivolumab treatment for hepatocellular carcinoma: should we use iRECIST?","volume":"8","author":"Lee","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.jhep.2026.03.004_bib143","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/s00261-021-03386-0","article-title":"Comparative assessment of standard and immune response criteria for evaluation of response to PD-1 monotherapy in unresectable HCC","volume":"47","author":"Lewis","year":"2022","journal-title":"Abdom Radiol (NY)"},{"key":"10.1016\/j.jhep.2026.03.004_bib144","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.764189","article-title":"Response evaluation and survival prediction following PD-1 inhibitor in patients with advanced hepatocellular carcinoma: comparison of the RECIST 1.1, iRECIST, and mRECIST criteria","volume":"11","author":"Zhou","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.jhep.2026.03.004_bib145","article-title":"Assessment of hepatocellular carcinoma response to (90)Y radioembolization using dynamic contrast material-enhanced MRI and intravoxel incoherent motion diffusion-weighted imaging","volume":"2","author":"Hectors","year":"2020","journal-title":"Radiol Imag Cancer"},{"key":"10.1016\/j.jhep.2026.03.004_bib146","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1002\/jmri.25617","article-title":"ADC(total) ratio and D ratio derived from intravoxel incoherent motion early after TACE are independent predictors for survival in hepatocellular carcinoma","volume":"46","author":"Wu","year":"2017","journal-title":"J Magn Reson Imag"},{"key":"10.1016\/j.jhep.2026.03.004_bib147","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1007\/s00330-023-10222-0","article-title":"Reclassification of therapeutic response of unresectable hepatocellular carcinoma to anti-angiogenic therapy and immunotherapy using alpha RECIST","volume":"34","author":"Xu","year":"2024","journal-title":"Eur Radiol"},{"issue":"1","key":"10.1016\/j.jhep.2026.03.004_bib148","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/s13244-025-02058-7","article-title":"Prognostic and predictive imaging markers of hepatocellular carcinoma: a pictorial essay","volume":"16","author":"Deyirmendjian","year":"2025","journal-title":"Insights Imaging"},{"issue":"1","key":"10.1016\/j.jhep.2026.03.004_bib149","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.221291","article-title":"CT radiomics to predict macrotrabecular-massive subtype and immune status in hepatocellular carcinoma","volume":"307","author":"Feng","year":"2023","journal-title":"Radiology"},{"issue":"6","key":"10.1016\/j.jhep.2026.03.004_bib150","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/j.jhep.2022.01.014","article-title":"Artificial intelligence for the prevention and clinical management of hepatocellular carcinoma","volume":"76","author":"Calderaro","year":"2022","journal-title":"J Hepatol"},{"issue":"12","key":"10.1016\/j.jhep.2026.03.004_bib151","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/s41571-023-00825-3","article-title":"Global trends in hepatocellular carcinoma epidemiology: implications for screening, prevention and therapy","volume":"20","author":"Singal","year":"2023","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.jhep.2026.03.004_bib152","doi-asserted-by":"crossref","first-page":"goaf018","DOI":"10.1093\/gastro\/goaf018","article-title":"Risk-stratified hepatocellular carcinoma surveillance in non-cirrhotic patients with MASLD","volume":"13","author":"Mi","year":"2025","journal-title":"Gastroenterol Rep (Oxf)"},{"issue":"1","key":"10.1016\/j.jhep.2026.03.004_bib153","doi-asserted-by":"crossref","first-page":"31","DOI":"10.17998\/jlc.2025.02.16","article-title":"Recent advances and issues in imaging modalities for hepatocellular carcinoma surveillance","volume":"25","author":"Lee","year":"2025","journal-title":"J Liver Cancer"},{"issue":"4","key":"10.1016\/j.jhep.2026.03.004_bib154","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1053\/j.gastro.2023.06.013","article-title":"AGA clinical practice update on the role of noninvasive biomarkers in the evaluation and management of nonalcoholic fatty liver disease: expert review","volume":"165","author":"Wattacheril","year":"2023","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.jhep.2026.03.004_bib155","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.222801","article-title":"LI-RADS: looking back, looking forward","volume":"307","author":"Chernyak","year":"2023","journal-title":"Radiology"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827826001297?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827826001297?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T16:54:21Z","timestamp":1789491261000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827826001297"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":155,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S0168827826001297"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2026.03.004","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advances in the imaging of liver cancer","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2026.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V. on behalf of European Association for the Study of the Liver.","name":"copyright","label":"Copyright"}]}}